0001140361-21-011505.txt : 20210405
0001140361-21-011505.hdr.sgml : 20210405
20210405090222
ACCESSION NUMBER: 0001140361-21-011505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GROSSMAN D KEITH
CENTRAL INDEX KEY: 0001218702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 21803874
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
form4.xml
FORM 4
X0306
4
2021-04-01
0001484612
Outset Medical, Inc.
OM
0001218702
GROSSMAN D KEITH
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
true
Common Stock
2021-04-01
4
M
0
2592
1.11
A
2592
D
Common Stock
2021-04-01
4
S
0
2592
55.062
D
0
D
Common Stock
11604
I
Held by The D. Keith and Hallie H. Grossman Family Living Trust
Stock Option (Right to Buy)
1.11
2021-04-01
4
M
0
2592
0
D
2024-06-16
Common Stock
2592
82325
D
These shares of common stock of the Issuer ("Shares") are held directly by The D. Keith and Hallie H. Grossman Family Living Trust, for which the reporting person and his spouse serve as trustees.
This option vested 25% on April 15, 2015, and then in 36 equal monthly installments thereafter.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $54.78 to $55.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
This Form 4 corrects the expiration date previously reported as April 16, 2024 on the Form 3 filed on September 14, 2020.
/s/ John L. Brottem, attorney-in-fact for Donald Keith Grossman
2021-04-05